NCT05387694View on ClinicalTrials.gov

Study of the Prognostic Value of the Coagulolytic Balance Dependent on Circulating Microvesicles in the Occurrence of Thrombotic Events After Total Knee Replacement in Orthopedic Surgery.

NANot yet recruitingINTERVENTIONAL
Enrollment

387

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Knee Prosthesis
Interventions
OTHER

Thrombotic risk assessment

Collection of symptomatic thrombotic events occurring during the 5 days of hospitalization and then by telephone interview at M1 +/- 3 days. Complete echodoppler (proximal and distal) performed at M1 to highlight asymptomatic thrombotic events.

Trial Locations (1)

13354

Assistance Publique Hopitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT05387694 - Study of the Prognostic Value of the Coagulolytic Balance Dependent on Circulating Microvesicles in the Occurrence of Thrombotic Events After Total Knee Replacement in Orthopedic Surgery. | Biotech Hunter | Biotech Hunter